Literature DB >> 2168729

The role of stereotactic radiosurgery in the management of intracranial tumors.

J S Loeffler1, E Alexander.   

Abstract

With the availability of gamma knife units and the development of modified linear accelerators, there is new interest in radiosurgery, especially as it applies to intracranial tumors. Among its advantages are the ability to precisely localize tumor and through small beam sizes deliver steep dose gradients at the field edges. This sharp dose gradient allows for the prescribed dose of radiation to be given to a tumor while avoiding vital structures only millimeters away. Radiosurgery has produced good results in the treatment of inoperable arteriovenous malformations and can be used as the sole curative therapy for small, radiographically distinct, benign noninvasive tumors. It is also used as salvage therapy in recurrent benign or malignant tumors that have previously been irradiated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168729

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  6 in total

1.  Towards frameless maskless SRS through real-time 6DoF robotic motion compensation.

Authors:  Andrew H Belcher; Xinmin Liu; Steven Chmura; Kamil Yenice; Rodney D Wiersma
Journal:  Phys Med Biol       Date:  2017-11-13       Impact factor: 3.609

2.  Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme.

Authors:  Christopher J Anker; Richard V Hymas; Lisa J Hazard; Kenneth M Boucher; Randy L Jensen; Dennis C Shrieve
Journal:  J Neurooncol       Date:  2010-04-10       Impact factor: 4.130

3.  Thallium-201 technetium-99m HMPAO single-photon emission computed tomography (SPECT) imaging for guiding stereotactic craniotomies in heavily irradiated malignant glioma patients.

Authors:  E Alexander; J S Loeffler; R B Schwartz; K A Johnson; P A Carvalho; B M Garada; R E Zimmerman; B L Holman
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 4.  The expanding role of chemotherapy for pediatric supratentorial malignant gliomas.

Authors:  D C Lyden; W P Mason; J L Finlay
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 5.  The therapy of primary brain lymphoma.

Authors:  F H Hochberg; J S Loeffler; M Prados
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

6.  Advantages of mini-multileaf in stereotactic radiotherapy.

Authors:  P G G Kurup; V Murali; A Sankar
Journal:  J Med Phys       Date:  2007-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.